Cargando…
Multicenter Case–Control Study of COVID-19–Associated Mucormycosis Outbreak, India
We performed a case–control study across 25 hospitals in India for the period of January–June 2021 to evaluate the reasons for an COVID-19–associated mucormycosis (CAM) outbreak. We investigated whether COVID-19 treatment practices (glucocorticoids, zinc, tocilizumab, and others) were associated wit...
Ejemplares similares
-
ICUs worldwide: Critical care in India
por: Prayag, Shirish
Publicado: (2002) -
Respiratory Care for Severe COVID-19
por: Prayag, Shirish
Publicado: (2020) -
The Dominance of Candida auris: A Single-center Experience of 79 Episodes of Candidemia from Western India
por: Prayag, Parikshit S, et al.
Publicado: (2022) -
Author Reply: Therapeutic Drug Monitoring of Isavuconazole: Lessons Learnt from a Real-life Setting in a Tertiary Care Center in India
por: Prayag, Parikshit Shirish
Publicado: (2023) -
COVID-19 patients’ clinical profile and outcome with respect to their vaccination status: A prospective observational multicentre cohort study during third wave in Western India
por: Patel, Atul K., et al.
Publicado: (2023)